Triazole derivatives which are Smo antagonists
Details for Australian Patent Application No. 2008241527 (hide)
International Classifications
Event Publications
5 November 2009 PCT application entered the National Phase
PCT publication WO2008/130552 Priority application(s): WO2008/130552
21 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
4 October 2012 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008241528-Novel opiate reduction utilizing catalytic hydrogen transfer reaction
2008241524-Heart failure detection using respiration distress manifestations
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser